🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our #MeetThePartner series continues with a very special guest. From ISGlobal , we present Dr José Muñoz, associate research professor and coordinator of our previous project #stoptheworm.

True innovation is about understanding the needs of the people it is for. In STOP2030, we aim to provide a new pharmacological tool for the control of #intestinalworms that is: ✔Simple ✔Easy to implement ✔Effective stop2030.org #WorldNTDDay #UniteActEliminate

Check out the results from our pivotal phase 2/3 clinical trial!🔴The ALIVE trial demonstrated the safety and superior efficacy of our co-formulation of #ivermectin and #albendazole in over 1000 participants. Full article available in The Lancet Infectious Diseases📄 thelancet.com/journals/lanin…

2025 marks the 5️⃣0️⃣-year anniversary of the discovery of #ivermectin, an essential drug to treat many #NTDs, including #strongyloidiasis A fixed-dose strategy for ivermectin can simplify treatment while reducing the risk of underdosing. Read our story stop2030.org/innovating-a-5…

#Strongyloides stercoralis was the last species to be included as a soil-transmitted helminth by WHO. What sets it apart? 🔬 Requires a different diagnostic technique (Baermann) 🔁 Presents a unique life cycle 💊 And its treatment of choice is #ivermectin

Innovations in #NTDcontrol are constantly emerging, particularly in technology. But how effective are these tools? These researchers have explored how advancements in #AI, robotics, and diagnostics are being tested and implemented in Africa nature.com/articles/s4146…

86 countries required preventive chemotherapy for soil-transmitted #helminths in 2023 💊 According to the latest Progress Report published by WHO, over 800 millionchildren worldwide needed treatment for #parasiticworms. Get the data in detail here iris.who.int/handle/10665/3…

🚀 Great news! The EU Medicines Agency has issued a positive opinion for a new treatment for parasitic worm infections! 🤝 This achievement is the result of a decade-long collaboration between Mundo Sano, Insud Pharma and EDCTP . 🔗Check the article europa.eu/!tVfCby

Our most important results to date, explained in under 2 min 🎬 Our phase II-III clinical trial ALIVE demonstrated our co-formulation is safe, and has superior efficacy against more species than the current standard. See why it matters 👇 youtube.com/watch?v=7UfJnp…

Our partners at Ghana Health Service recently hosted a key stakeholder meeting towards the implementation of paediatric #praziquantel against #schistosomiasis. Our colleague Dr. Joseph Opare shares valuable insights on the impact and next steps undp.org/ghana/press-re…

Discover our co-formulation 💊 Fixed-dose, mouth-dissolving and easy to administer 🥭 Mango-flavoured 〰 Covers all STH species considered in WHO’s Roadmap 📋 Proven efficacy and safety 📦 And getting ready for implementation Stay tuned for the start of our phase IV trial!

According to the latest WHO’s progress report, more than half of the school-aged children in need of STH treatments received coverage by preventive #chemotherapy campaigns in 2023. That’s over 354 million children treated all over the world!

Last week, Julie Jacobson was proud to participate in Mundo Sano 's 1st annual Global Health conference in Madrid! She spoke to challenges in NTD elimination programs and solutions such as STOP2030 novel fixed-dose coformulation of ivermectin and albendazole for STH. #beatNTDs

Quick recap from #EDCTPForum2025! Grateful to join this vital meeting advancing the fight against #NTDs. 🩺 Alejandro Krolewiecki spoke on behalf of STOP2030 among many key voices driving change. 🌍